nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—myometrium—uterine cancer	0.0177	0.153	CbGeAlD
Emtricitabine—DCK—uterine cervix—uterine cancer	0.0138	0.119	CbGeAlD
Emtricitabine—DCK—decidua—uterine cancer	0.0131	0.113	CbGeAlD
Emtricitabine—DCK—endometrium—uterine cancer	0.0125	0.108	CbGeAlD
Emtricitabine—DCK—mammalian vulva—uterine cancer	0.0121	0.104	CbGeAlD
Emtricitabine—DCK—uterus—uterine cancer	0.0115	0.0993	CbGeAlD
Emtricitabine—DCK—female reproductive system—uterine cancer	0.0103	0.0892	CbGeAlD
Emtricitabine—DCK—Doxorubicin—Epirubicin—uterine cancer	0.00964	0.38	CbGdCrCtD
Emtricitabine—DCK—female gonad—uterine cancer	0.0094	0.0812	CbGeAlD
Emtricitabine—DCK—vagina—uterine cancer	0.00935	0.0807	CbGeAlD
Emtricitabine—DCK—Epirubicin—Doxorubicin—uterine cancer	0.00892	0.351	CbGdCrCtD
Emtricitabine—DCK—Levonorgestrel—Progesterone—uterine cancer	0.00682	0.269	CbGdCrCtD
Emtricitabine—DCK—lymph node—uterine cancer	0.00604	0.0522	CbGeAlD
Emtricitabine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00243	0.00283	CcSEcCtD
Emtricitabine—Insomnia—Progesterone—uterine cancer	0.00241	0.00281	CcSEcCtD
Emtricitabine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.0028	CcSEcCtD
Emtricitabine—Paraesthesia—Progesterone—uterine cancer	0.0024	0.00279	CcSEcCtD
Emtricitabine—Dyspnoea—Progesterone—uterine cancer	0.00238	0.00277	CcSEcCtD
Emtricitabine—Skin discolouration—Epirubicin—uterine cancer	0.00238	0.00277	CcSEcCtD
Emtricitabine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00276	CcSEcCtD
Emtricitabine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00237	0.00276	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.00236	0.00275	CcSEcCtD
Emtricitabine—Dyspepsia—Progesterone—uterine cancer	0.00235	0.00274	CcSEcCtD
Emtricitabine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00235	0.00274	CcSEcCtD
Emtricitabine—Cough increased—Epirubicin—uterine cancer	0.00234	0.00273	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Progesterone—uterine cancer	0.0023	0.00268	CcSEcCtD
Emtricitabine—Fatigue—Progesterone—uterine cancer	0.0023	0.00268	CcSEcCtD
Emtricitabine—Pain—Progesterone—uterine cancer	0.00228	0.00266	CcSEcCtD
Emtricitabine—Creatinine increased—Epirubicin—uterine cancer	0.00225	0.00262	CcSEcCtD
Emtricitabine—Neutropenia—Etoposide—uterine cancer	0.00225	0.00261	CcSEcCtD
Emtricitabine—Bone pain—Epirubicin—uterine cancer	0.00224	0.00261	CcSEcCtD
Emtricitabine—Inflammation—Epirubicin—uterine cancer	0.00221	0.00258	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.00257	CcSEcCtD
Emtricitabine—Skin discolouration—Doxorubicin—uterine cancer	0.0022	0.00256	CcSEcCtD
Emtricitabine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00219	0.00255	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.00218	0.00254	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Progesterone—uterine cancer	0.00218	0.00254	CcSEcCtD
Emtricitabine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00253	CcSEcCtD
Emtricitabine—Cough increased—Doxorubicin—uterine cancer	0.00217	0.00253	CcSEcCtD
Emtricitabine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00251	CcSEcCtD
Emtricitabine—Pneumonia—Etoposide—uterine cancer	0.00215	0.00251	CcSEcCtD
Emtricitabine—Infestation NOS—Etoposide—uterine cancer	0.00214	0.00249	CcSEcCtD
Emtricitabine—Infestation—Etoposide—uterine cancer	0.00214	0.00249	CcSEcCtD
Emtricitabine—Anaemia—Dactinomycin—uterine cancer	0.00214	0.00249	CcSEcCtD
Emtricitabine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.00248	CcSEcCtD
Emtricitabine—Urticaria—Progesterone—uterine cancer	0.00212	0.00247	CcSEcCtD
Emtricitabine—Abnormal dreams—Epirubicin—uterine cancer	0.00212	0.00247	CcSEcCtD
Emtricitabine—Abdominal pain—Progesterone—uterine cancer	0.00211	0.00246	CcSEcCtD
Emtricitabine—Body temperature increased—Progesterone—uterine cancer	0.00211	0.00246	CcSEcCtD
Emtricitabine—Renal failure—Etoposide—uterine cancer	0.0021	0.00245	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Etoposide—uterine cancer	0.0021	0.00244	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00243	CcSEcCtD
Emtricitabine—Creatinine increased—Doxorubicin—uterine cancer	0.00209	0.00243	CcSEcCtD
Emtricitabine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00209	0.00243	CcSEcCtD
Emtricitabine—Bone pain—Doxorubicin—uterine cancer	0.00207	0.00241	CcSEcCtD
Emtricitabine—Inflammation—Doxorubicin—uterine cancer	0.00205	0.00238	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Etoposide—uterine cancer	0.00203	0.00236	CcSEcCtD
Emtricitabine—Neuropathy—Epirubicin—uterine cancer	0.00201	0.00235	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.0023	CcSEcCtD
Emtricitabine—Myalgia—Dactinomycin—uterine cancer	0.00197	0.00229	CcSEcCtD
Emtricitabine—Hypersensitivity—Progesterone—uterine cancer	0.00197	0.00229	CcSEcCtD
Emtricitabine—Abnormal dreams—Doxorubicin—uterine cancer	0.00196	0.00228	CcSEcCtD
Emtricitabine—Rash maculo-papular—Epirubicin—uterine cancer	0.00195	0.00227	CcSEcCtD
Emtricitabine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.00224	CcSEcCtD
Emtricitabine—Asthenia—Progesterone—uterine cancer	0.00192	0.00223	CcSEcCtD
Emtricitabine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00223	CcSEcCtD
Emtricitabine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00191	0.00223	CcSEcCtD
Emtricitabine—Urinary tract disorder—Etoposide—uterine cancer	0.0019	0.00221	CcSEcCtD
Emtricitabine—Pruritus—Progesterone—uterine cancer	0.00189	0.0022	CcSEcCtD
Emtricitabine—Urethral disorder—Etoposide—uterine cancer	0.00188	0.00219	CcSEcCtD
Emtricitabine—Infection—Dactinomycin—uterine cancer	0.00187	0.00218	CcSEcCtD
Emtricitabine—Neuropathy—Doxorubicin—uterine cancer	0.00186	0.00217	CcSEcCtD
Emtricitabine—Thrombocytopenia—Dactinomycin—uterine cancer	0.00185	0.00215	CcSEcCtD
Emtricitabine—Diarrhoea—Progesterone—uterine cancer	0.00183	0.00213	CcSEcCtD
Emtricitabine—Rash maculo-papular—Doxorubicin—uterine cancer	0.0018	0.0021	CcSEcCtD
Emtricitabine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00208	CcSEcCtD
Emtricitabine—Dizziness—Progesterone—uterine cancer	0.00177	0.00206	CcSEcCtD
Emtricitabine—Immune system disorder—Etoposide—uterine cancer	0.00174	0.00202	CcSEcCtD
Emtricitabine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00202	CcSEcCtD
Emtricitabine—Mediastinal disorder—Etoposide—uterine cancer	0.00173	0.00202	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00172	0.002	CcSEcCtD
Emtricitabine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00199	CcSEcCtD
Emtricitabine—Vomiting—Progesterone—uterine cancer	0.0017	0.00198	CcSEcCtD
Emtricitabine—Renal failure acute—Epirubicin—uterine cancer	0.00169	0.00196	CcSEcCtD
Emtricitabine—Rash—Progesterone—uterine cancer	0.00168	0.00196	CcSEcCtD
Emtricitabine—Dermatitis—Progesterone—uterine cancer	0.00168	0.00196	CcSEcCtD
Emtricitabine—Headache—Progesterone—uterine cancer	0.00167	0.00195	CcSEcCtD
Emtricitabine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.00193	CcSEcCtD
Emtricitabine—Renal impairment—Epirubicin—uterine cancer	0.00164	0.00191	CcSEcCtD
Emtricitabine—Dermatitis bullous—Epirubicin—uterine cancer	0.00163	0.0019	CcSEcCtD
Emtricitabine—Fatigue—Dactinomycin—uterine cancer	0.00163	0.00189	CcSEcCtD
Emtricitabine—Back pain—Etoposide—uterine cancer	0.00162	0.00188	CcSEcCtD
Emtricitabine—Pain—Dactinomycin—uterine cancer	0.00161	0.00188	CcSEcCtD
Emtricitabine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00186	CcSEcCtD
Emtricitabine—Nausea—Progesterone—uterine cancer	0.00159	0.00185	CcSEcCtD
Emtricitabine—Renal failure acute—Doxorubicin—uterine cancer	0.00156	0.00182	CcSEcCtD
Emtricitabine—Anaemia—Etoposide—uterine cancer	0.00155	0.0018	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00154	0.0018	CcSEcCtD
Emtricitabine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00179	CcSEcCtD
Emtricitabine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.00178	CcSEcCtD
Emtricitabine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00177	CcSEcCtD
Emtricitabine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00176	CcSEcCtD
Emtricitabine—Renal impairment—Doxorubicin—uterine cancer	0.00151	0.00176	CcSEcCtD
Emtricitabine—Dermatitis bullous—Doxorubicin—uterine cancer	0.00151	0.00176	CcSEcCtD
Emtricitabine—Abdominal pain—Dactinomycin—uterine cancer	0.00149	0.00174	CcSEcCtD
Emtricitabine—Body temperature increased—Dactinomycin—uterine cancer	0.00149	0.00174	CcSEcCtD
Emtricitabine—Cough—Etoposide—uterine cancer	0.00146	0.0017	CcSEcCtD
Emtricitabine—Blood creatinine increased—Epirubicin—uterine cancer	0.00146	0.0017	CcSEcCtD
Emtricitabine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00167	CcSEcCtD
Emtricitabine—Hypokalaemia—Epirubicin—uterine cancer	0.00142	0.00165	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00141	0.00165	CcSEcCtD
Emtricitabine—Breast disorder—Epirubicin—uterine cancer	0.00141	0.00164	CcSEcCtD
Emtricitabine—Nasopharyngitis—Epirubicin—uterine cancer	0.00139	0.00162	CcSEcCtD
Emtricitabine—Hypersensitivity—Dactinomycin—uterine cancer	0.00139	0.00162	CcSEcCtD
Emtricitabine—Muscular weakness—Epirubicin—uterine cancer	0.00137	0.0016	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00137	0.0016	CcSEcCtD
Emtricitabine—Infection—Etoposide—uterine cancer	0.00136	0.00158	CcSEcCtD
Emtricitabine—Asthenia—Dactinomycin—uterine cancer	0.00135	0.00158	CcSEcCtD
Emtricitabine—Blood creatinine increased—Doxorubicin—uterine cancer	0.00135	0.00157	CcSEcCtD
Emtricitabine—Thrombocytopenia—Etoposide—uterine cancer	0.00134	0.00156	CcSEcCtD
Emtricitabine—Skin disorder—Etoposide—uterine cancer	0.00133	0.00154	CcSEcCtD
Emtricitabine—Pancreatitis—Epirubicin—uterine cancer	0.00132	0.00154	CcSEcCtD
Emtricitabine—Hypokalaemia—Doxorubicin—uterine cancer	0.00131	0.00153	CcSEcCtD
Emtricitabine—Breast disorder—Doxorubicin—uterine cancer	0.0013	0.00152	CcSEcCtD
Emtricitabine—Diarrhoea—Dactinomycin—uterine cancer	0.00129	0.0015	CcSEcCtD
Emtricitabine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00129	0.0015	CcSEcCtD
Emtricitabine—Muscular weakness—Doxorubicin—uterine cancer	0.00127	0.00148	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00127	0.00148	CcSEcCtD
Emtricitabine—Neutropenia—Epirubicin—uterine cancer	0.00126	0.00147	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00125	0.00146	CcSEcCtD
Emtricitabine—Paraesthesia—Etoposide—uterine cancer	0.00123	0.00143	CcSEcCtD
Emtricitabine—Pancreatitis—Doxorubicin—uterine cancer	0.00122	0.00142	CcSEcCtD
Emtricitabine—Weight decreased—Epirubicin—uterine cancer	0.00122	0.00142	CcSEcCtD
Emtricitabine—Dyspnoea—Etoposide—uterine cancer	0.00122	0.00142	CcSEcCtD
Emtricitabine—Hyperglycaemia—Epirubicin—uterine cancer	0.00121	0.00141	CcSEcCtD
Emtricitabine—Pneumonia—Epirubicin—uterine cancer	0.00121	0.00141	CcSEcCtD
Emtricitabine—Infestation NOS—Epirubicin—uterine cancer	0.0012	0.0014	CcSEcCtD
Emtricitabine—Infestation—Epirubicin—uterine cancer	0.0012	0.0014	CcSEcCtD
Emtricitabine—Vomiting—Dactinomycin—uterine cancer	0.0012	0.0014	CcSEcCtD
Emtricitabine—Rash—Dactinomycin—uterine cancer	0.00119	0.00139	CcSEcCtD
Emtricitabine—Renal failure—Epirubicin—uterine cancer	0.00118	0.00137	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00118	0.00137	CcSEcCtD
Emtricitabine—Fatigue—Etoposide—uterine cancer	0.00118	0.00137	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Epirubicin—uterine cancer	0.00118	0.00137	CcSEcCtD
Emtricitabine—Pain—Etoposide—uterine cancer	0.00117	0.00136	CcSEcCtD
Emtricitabine—Urinary tract infection—Epirubicin—uterine cancer	0.00117	0.00136	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—uterine cancer	0.00116	0.00136	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00116	0.00135	CcSEcCtD
Emtricitabine—Haematuria—Epirubicin—uterine cancer	0.00114	0.00133	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Epirubicin—uterine cancer	0.00114	0.00132	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—uterine cancer	0.00113	0.00131	CcSEcCtD
Emtricitabine—Sinusitis—Epirubicin—uterine cancer	0.00113	0.00131	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—uterine cancer	0.00112	0.00131	CcSEcCtD
Emtricitabine—Nausea—Dactinomycin—uterine cancer	0.00112	0.0013	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—uterine cancer	0.00112	0.0013	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Etoposide—uterine cancer	0.00112	0.0013	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—uterine cancer	0.00111	0.00129	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—uterine cancer	0.00111	0.00129	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—uterine cancer	0.00109	0.00127	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.00109	0.00127	CcSEcCtD
Emtricitabine—Urticaria—Etoposide—uterine cancer	0.00108	0.00126	CcSEcCtD
Emtricitabine—Rhinitis—Epirubicin—uterine cancer	0.00108	0.00126	CcSEcCtD
Emtricitabine—Abdominal pain—Etoposide—uterine cancer	0.00108	0.00126	CcSEcCtD
Emtricitabine—Body temperature increased—Etoposide—uterine cancer	0.00108	0.00126	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—uterine cancer	0.00108	0.00126	CcSEcCtD
Emtricitabine—Hepatitis—Epirubicin—uterine cancer	0.00108	0.00125	CcSEcCtD
Emtricitabine—Pharyngitis—Epirubicin—uterine cancer	0.00107	0.00125	CcSEcCtD
Emtricitabine—Urinary tract disorder—Epirubicin—uterine cancer	0.00106	0.00124	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—uterine cancer	0.00106	0.00123	CcSEcCtD
Emtricitabine—Connective tissue disorder—Epirubicin—uterine cancer	0.00106	0.00123	CcSEcCtD
Emtricitabine—Urethral disorder—Epirubicin—uterine cancer	0.00106	0.00123	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00105	0.00122	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—uterine cancer	0.00104	0.00121	CcSEcCtD
Emtricitabine—Hypersensitivity—Etoposide—uterine cancer	0.00101	0.00117	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—uterine cancer	0.000999	0.00116	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—uterine cancer	0.000997	0.00116	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—uterine cancer	0.000989	0.00115	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000985	0.00115	CcSEcCtD
Emtricitabine—Asthenia—Etoposide—uterine cancer	0.00098	0.00114	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—uterine cancer	0.00098	0.00114	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—uterine cancer	0.000977	0.00114	CcSEcCtD
Emtricitabine—Immune system disorder—Epirubicin—uterine cancer	0.000973	0.00113	CcSEcCtD
Emtricitabine—Mediastinal disorder—Epirubicin—uterine cancer	0.000971	0.00113	CcSEcCtD
Emtricitabine—Pruritus—Etoposide—uterine cancer	0.000966	0.00112	CcSEcCtD
Emtricitabine—Mental disorder—Epirubicin—uterine cancer	0.000944	0.0011	CcSEcCtD
Emtricitabine—Malnutrition—Epirubicin—uterine cancer	0.000938	0.00109	CcSEcCtD
Emtricitabine—Diarrhoea—Etoposide—uterine cancer	0.000934	0.00109	CcSEcCtD
Emtricitabine—Back pain—Epirubicin—uterine cancer	0.000907	0.00106	CcSEcCtD
Emtricitabine—Dizziness—Etoposide—uterine cancer	0.000903	0.00105	CcSEcCtD
Emtricitabine—Immune system disorder—Doxorubicin—uterine cancer	0.0009	0.00105	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000898	0.00105	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—uterine cancer	0.000873	0.00102	CcSEcCtD
Emtricitabine—Vomiting—Etoposide—uterine cancer	0.000868	0.00101	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—uterine cancer	0.000868	0.00101	CcSEcCtD
Emtricitabine—Anaemia—Epirubicin—uterine cancer	0.000867	0.00101	CcSEcCtD
Emtricitabine—Rash—Etoposide—uterine cancer	0.000861	0.001	CcSEcCtD
Emtricitabine—Dermatitis—Etoposide—uterine cancer	0.00086	0.001	CcSEcCtD
Emtricitabine—Headache—Etoposide—uterine cancer	0.000856	0.000996	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—uterine cancer	0.000839	0.000977	CcSEcCtD
Emtricitabine—Cough—Epirubicin—uterine cancer	0.000818	0.000953	CcSEcCtD
Emtricitabine—Nausea—Etoposide—uterine cancer	0.000811	0.000944	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—uterine cancer	0.000802	0.000934	CcSEcCtD
Emtricitabine—Myalgia—Epirubicin—uterine cancer	0.000799	0.00093	CcSEcCtD
Emtricitabine—Arthralgia—Epirubicin—uterine cancer	0.000799	0.00093	CcSEcCtD
Emtricitabine—Anxiety—Epirubicin—uterine cancer	0.000796	0.000927	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000793	0.000923	CcSEcCtD
Emtricitabine—Infection—Epirubicin—uterine cancer	0.00076	0.000885	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—uterine cancer	0.000757	0.000882	CcSEcCtD
Emtricitabine—Nervous system disorder—Epirubicin—uterine cancer	0.000751	0.000874	CcSEcCtD
Emtricitabine—Thrombocytopenia—Epirubicin—uterine cancer	0.000749	0.000873	CcSEcCtD
Emtricitabine—Skin disorder—Epirubicin—uterine cancer	0.000744	0.000866	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—uterine cancer	0.000739	0.00086	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—uterine cancer	0.000739	0.00086	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—uterine cancer	0.000736	0.000857	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000734	0.000854	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—uterine cancer	0.000704	0.000819	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000697	0.000812	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—uterine cancer	0.000695	0.000809	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000693	0.000807	CcSEcCtD
Emtricitabine—Insomnia—Epirubicin—uterine cancer	0.000692	0.000806	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—uterine cancer	0.000688	0.000801	CcSEcCtD
Emtricitabine—Paraesthesia—Epirubicin—uterine cancer	0.000687	0.0008	CcSEcCtD
Emtricitabine—Dyspnoea—Epirubicin—uterine cancer	0.000682	0.000795	CcSEcCtD
Emtricitabine—Dyspepsia—Epirubicin—uterine cancer	0.000674	0.000785	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000661	0.00077	CcSEcCtD
Emtricitabine—Fatigue—Epirubicin—uterine cancer	0.00066	0.000768	CcSEcCtD
Emtricitabine—Pain—Epirubicin—uterine cancer	0.000655	0.000762	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000645	0.000751	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—uterine cancer	0.000641	0.000746	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—uterine cancer	0.000636	0.000741	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—uterine cancer	0.000631	0.000735	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000626	0.000729	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—uterine cancer	0.000623	0.000726	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000611	0.000712	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—uterine cancer	0.000611	0.000711	CcSEcCtD
Emtricitabine—Urticaria—Epirubicin—uterine cancer	0.000608	0.000708	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—uterine cancer	0.000606	0.000705	CcSEcCtD
Emtricitabine—Body temperature increased—Epirubicin—uterine cancer	0.000605	0.000705	CcSEcCtD
Emtricitabine—Abdominal pain—Epirubicin—uterine cancer	0.000605	0.000705	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000579	0.000674	CcSEcCtD
Emtricitabine—Hypersensitivity—Epirubicin—uterine cancer	0.000564	0.000657	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—uterine cancer	0.000563	0.000655	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—uterine cancer	0.00056	0.000652	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—uterine cancer	0.00056	0.000652	CcSEcCtD
Emtricitabine—Asthenia—Epirubicin—uterine cancer	0.000549	0.00064	CcSEcCtD
Emtricitabine—Pruritus—Epirubicin—uterine cancer	0.000542	0.000631	CcSEcCtD
Emtricitabine—Diarrhoea—Epirubicin—uterine cancer	0.000524	0.00061	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—uterine cancer	0.000522	0.000608	CcSEcCtD
Emtricitabine—Asthenia—Doxorubicin—uterine cancer	0.000508	0.000592	CcSEcCtD
Emtricitabine—Dizziness—Epirubicin—uterine cancer	0.000506	0.000589	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—uterine cancer	0.000501	0.000583	CcSEcCtD
Emtricitabine—Vomiting—Epirubicin—uterine cancer	0.000487	0.000567	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—uterine cancer	0.000485	0.000564	CcSEcCtD
Emtricitabine—Rash—Epirubicin—uterine cancer	0.000483	0.000562	CcSEcCtD
Emtricitabine—Dermatitis—Epirubicin—uterine cancer	0.000482	0.000561	CcSEcCtD
Emtricitabine—Headache—Epirubicin—uterine cancer	0.00048	0.000558	CcSEcCtD
Emtricitabine—Dizziness—Doxorubicin—uterine cancer	0.000468	0.000545	CcSEcCtD
Emtricitabine—Nausea—Epirubicin—uterine cancer	0.000455	0.000529	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—uterine cancer	0.00045	0.000524	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—uterine cancer	0.000447	0.00052	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—uterine cancer	0.000446	0.00052	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—uterine cancer	0.000444	0.000517	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—uterine cancer	0.000421	0.00049	CcSEcCtD
